SNPTF
Sunny Optical Technology (Group) Co Limited$7.77 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $7.77
1 year
−26.0%
from $10.50 · Oct 28
30 days
−10.5%
from $8.69
52-week range
$6.61–10.50
−26% from high · low Mar 20
Avg volume 20D
15
Oct 9 spike 300
Short interest
817.5K
−9.8%
Days to cover
101.1
at average volume
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 31 Short interest falls 76.7% to 1.76M
- X Aug 31 Short interest jumps 57.0% to 2.41M
- X Sep 15 Short interest falls 58.5% to 999.5K
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest −9.8% to 817.5K shares. 101.1 days to cover.
- TrendDOWNTREND
4% below its 50-day average.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 12, 2026
FDA
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
Class I: Presence of Particulate Matter; identified as stainless steel
Aug 12, 2026
FDA
Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1
Class I: Presence of Particulate Matter; identified as stainless steel
Aug 12, 2026
FDA
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
Class I: Presence of Particulate Matter; identified as stainless steel
Aug 12, 2026
FDA
Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1
Class I: Presence of Particulate Matter; identified as stainless steel
Aug 12, 2026
FDA
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
Class I: Presence of Particulate Matter; identified as stainless steel
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026817,455
shares short
-9.8%
vs prior settlement
101.1
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 Event
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
Class I: Presence of Particulate Matter; identified as stainless steel